[Pneumococcal infections: Appraisal and perspectives in terms of adult vaccination]

Laila Baratali; Pierre Olivier Lang

doi:10.1016/j.lpm.2015.04.038

[Pneumococcal infections: Appraisal and perspectives in terms of adult vaccination]

Presse Med. 2015 Nov;44(11):1155-61. doi: 10.1016/j.lpm.2015.04.038. Epub 2015 Sep 9.

[Article in French]

Authors

Laila Baratali¹, Pierre Olivier Lang²

Affiliations

¹ CHUV, service de médecine interne, 46, rue du Bugnon, 1011 Lausanne, Suisse.
² CHUV, service de médecine interne, 46, rue du Bugnon, 1011 Lausanne, Suisse; CHUV, service de gériatrie et de réhabilitation gériatrique, Mont Paisible 16 (MP16/04/414), 1011 Lausanne, Suisse; Anglia Ruskin University, Health and wellbeing academy, Cambridge, Royaume-Uni. Electronic address: pierre-olivier.lang@chuv.ch.

PMID: 26363530
DOI: 10.1016/j.lpm.2015.04.038

Abstract

Pneumococcal diseases are the first cause of bacterial infections in adult and in the aged adult. While its considerable morbi-mortality is potentially preventable through vaccination, the interest of anti-pneumococcal vaccination in these populations is still debated. Effectiveness appraisal of current anti-pneumococcal vaccines and the perspectives in terms of preventive strategies against Streptococcus pneumoniae infections in the adult population are presented.

Publication types

English Abstract
Review

MeSH terms

Adult
Age Factors
Antibodies, Bacterial / immunology
Antigens, Bacterial / immunology
Child, Preschool
Humans
Immunization Schedule
Incidence
Infant
Pneumococcal Infections / epidemiology
Pneumococcal Infections / prevention & control*
Pneumococcal Vaccines*
Polysaccharides, Bacterial / immunology
Practice Guidelines as Topic
Serotyping
Streptococcus pneumoniae / classification
Streptococcus pneumoniae / immunology
Vaccination*
Vaccines, Conjugate

Substances

Antibodies, Bacterial
Antigens, Bacterial
Pneumococcal Vaccines
Polysaccharides, Bacterial
Vaccines, Conjugate